Life Sciences Solutions

 

Confidence in validation
Is validation important to you? Understanding the importance and complexity of validation can reduce the cost, time and confusion of the regulatory process. Have confidence in solutions provided by experienced, dedicated, specialist teams that have implemented the successful completion of validated solutions around the world.

Active response to the latest regulatory developments e.g. PAT.

● "Test and validate once - use many times" engineering strategy.
● Built in 21 CFR Part 11 features.
● "Wrap & Comply" solution upgrade validation path.
● Standard validation templates.
 

Confidence in measured value for your money
Do you want to minimize cost and maximize productivity? And would you like our team to work with your team to partner for success?

● Consultancy services to ensure you get exactly what you need.
● Consultancy to help you reduce validation time, costs and confusion.
● Global and plant wide consistency - re-using engineering to minimize costs.
● Complete life cycle support - maximizing productivity and efficiency.
● Lifetime service level agreements to protect your investment.
● A complete range of services designed to provide you with the best value from your system -

               ● Installation
               ● Commissioning
               ● Training
               ● Calibration
               ● Spares management
               ● Technical support

Customer Quotes

"We felt, right from the start of this project, that the proposed EurothermSuite / Visual Supervisor solution could be ideally suited to meeting the requirements of the new LSL facility.

It provides capabilities normally inherent within considerably more expensive DCS solutions and represents a much lower-risk option than PLC/SCADA architectures, where computer validation and 21CFR part 11 compliance were considered more difficult.

In addition, Eurotherm demonstrated its commitment to the project by assigning highly competent project management and engineering personnel within their team.

Applications requirements were reflected accurately within high-quality design documentation fully compliant with GAMP requirements.

The attention to detail at this stage contributed to successful code implementation and customer acceptance testing."

comments Chris Southan: Lead Control and Instrumentation Engineer at Jacobs.

The Large Scale Labs solution was a typical example of a joint effort, in which Eurotherm engineers worked closely with AstraZeneca staff and Jacobs, who managed the project on behalf of AstraZeneca.
Applications in Life Sciences:

BMS and EMS (Building Management Systems and Environmental Monitoring Systems)
Fermentation Solutions
Freeze Drying Solutions
Hydrogenation Solutions
Tablet Coating Solutions
Water Purification Solutions
Spray Drying Solutions
Sterlization Solutions
EtO Sterlization Solutions
Environmental and Stability Chambers Solutions


Regulatory Compliance:

21 CFR Part 11
PAT



Complete BMS and EMS Solutions
Why BMS/EMS?

“Where environmental conditions could reasonably be expected to have an adverse effect on product quality, the manufacturer shall establish and maintain procedures to adequately control these environmental conditions.

Environmental control system(s) shall be periodically inspected to verify that the system, including necessary equipment, is adequate and functioning properly. These activities shall be documented and reviewed.”


FDA 21 CFR Part 820.70 Production and Process Controls, section c.

Control and monitoring of storage and production environments has become an important issue within the Pharmaceutical Industry. The FDA, EMEA and other regulatory bodies require accurate measurement and storage of room parameters and, if the storage medium is electronic, the methods used must comply with 21 CFR Part 11.

The FDA also states in its 21 CFR part 203.32 that:

“Manufacturers; authorised distributors of record and their representatives shall store and handle all drug samples under conditions that will maintain their stability, integrity and effectiveness and ensure that the drug samples are free of contamination, deterioration, and adulteration.”

Other FDA rules related to environmental control and monitoring include:

● 211.42: Design and construction features (section 10)
● 211.46: Ventilation, air filtration, air heating and cooling
● 211.142: Warehousing procedures (section b)
● 820.70: Production and process controls
● ICH Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients (sections 4.2 and 10)

Why Eurotherm?
The Eurotherm BMS/EMS system is designed to satisfy the requirements of regulatory bodies including 21 CFR Part 11 and it offers:

● Scalable from a single room to a plant wide solution
● Simplifies validation using flexible and modular standard functions
● Accurate and effective control of HVAC systems and other related equipment
● Centralized and/or remote control of facilities and equipment
● Real time Monitoring of BMS performance
● Intelligent alarm capability for early warning of process deviations
● Corrective strategies when stability factors go outside the specification
● Secure management and storage of environmental data and audit trails
● Predictive maintenance planning
● Energy management

Scalable BMS/EMS Solutions from Eurotherm
Eurotherm Building Management Systems provide control, monitoring, recording and alarming of a range of facilities within a plant including:

● Production facilities including Aseptic areas
● Laboratory facilities
● Warehouse facilities
● Cold storage facilities
● Environmental Chambers
● Office facilities
● Fire and alarm security systems
● Water purification systems

Not all existing BMS systems offer a logging facility and, for these systems an independent monitoring system, EMS, will be needed. Typically an EMS will provide independent monitoring and logging of the critical environmental parameters for GMP, GLP and GDP facilities.

Flexible and Modular BMS/EMS Solution
Eurotherm BMS/EMS Standard Modules

Eurotherm BMS/EMS solutions are modular and scalable.

They offer all the functionality required to control, monitor, record and alarm, for a single room to a plant wide application.

They are ideal for

■ Implementing a new system
■ Enhancing existing systems
■ EMS for an existing BMS

It offers the options for:

■ Centralized BMS/EMS
■ Network of local standalone BMS/EMS units
■ Combination of centralized and local systems to increase availability and ease of use

Sensor
Sensors communicate measurement and status information from the process to the control and monitoring modules of the BMS/EMS system. Sensors include:

● Temperature
● Relative Humidity
● Air pressure or differential Pressures
● Luminescence (light level)
● Particle counters
● Air Flow patterns
● Gas Level
● Vibration
● Noise
● Water leak detection
● Doors status
● Fire detectors
● HVAC healthy status

For hazardous rooms intrinsically safe devices must be used including:

● Intrinsically Safe sensors
● Intrinsically Safe barrier
● Intrinsically Safe IO modules

Eurotherm can offer a range of the above sensors or alternatively provide interface to sensors supplied by the user.

Accurate Control with Redundancy Option
Monitoring

BMS/EMS offer a wide range of options for monitoring the plant. Information can be monitored locally, centrally and remotely. Access to the system is protected. Users must login to gain access to functionality, defined by their access level.

Plant information is monitored through standard and custom displays and includes:

● Live data
● Mimics with live data
● Multi language support

Information received from the plant is grouped together in various forms to allow the users to rapidly access the required information. The system utilizes an easy to use, hierarchical methodology of presenting the necessary information to the users including:

● Plant overview
● Area overview
● Individual room overview
● Individual control loop view
● Individual sensor view
● Grouping by type (e.g. temperature, humidity, pressure)

Data collected from the plant are linked together and displayed as trends using online and historical trending within the system.

Trended data are available in various groups e.g. by room, by type (temperature, pressure etc.) The monitoring facility also provides the user with access to standard features of the system according to their access level, including:

● Access control with password protection for individual user accounts, inactivity timeout and password expiry
● Alarms
● Trends
● Alarm set point configuration
● Control parameter configuration
● Calibration facilities
● Maintenance facilities
● Batch displays
● Electronic signatures
● Configuration utilities
● Multi language support

Control
The purpose of this component is to provide the control of the necessary parameters for each individual room/area. It offers standard control functionality, e.g. PID loops, to accurately control the various environmental conditions of the room.

It also provides the functionality required to control devices such as pumps, motors and valves, e.g. start/stop with necessary interlocks. Operation can be configured to be automatic, semi-automatic, manual or any combination of these.
 
Individual rooms/areas may be operated in different modes; the selecting of which is access controlled by authorized users:

● Idle: Option for turning off the control of the critical parameters
● In operation: Automatic control of critical parameters
● Maintenance: Automatic and Manual control of critical parameters. This mode is also used for calibration of sensors.

BMS offer the facility for adjusting control parameters (e.g. setpoints, alarm limits, tolerances, time delays) in order to achieve the desired condition in each room. This feature is only available to users with the appropriate access permissions. The system provides a full audit trail of these changes including electronic signatures.

Data Logging and Audit Trail Designed to Satisfy 21 CFR Part 11
Data Logging

Data logging is a key requirement for BMS/EMS systems. 21 CFR Part 11 requires that logged data will be tamper proof and will include critical environmental parameters (temperature, humidity, pressure, particulate sizes, etc), with audit trails including:

● Accurate time and date stamps
● Alarms and events
● User actions and details (e.g. setpoint changes)
● User notes
● Electronic Signatures
● Login/Logout

Eurotherm’s BMS/EMS systems log plant data to tamper proof files and SQL relational databases. Data logging can be offered as:

● Local logging (Tamper proof file)
● Central logging (SQL database)
● Local and central logging (Tamper proof files and SQL database)

The availability of logged data can be significantly increased by the local and central logging option. This allows data collection in multiple devices to further protect vital plant data.

Typically a BMS/EMS system comprises of a number of distributed units where each unit has its own internal clock. Time synchronisation is included to ensure accurate time and date stamps, as required by 21 CFR Part 11, to a known clock source.

The BMS/EMS system offers provisions for electronically copying data for archive and export facility to common packages (e.g. Excel, Word, PDF, etc.) for viewing of secure records in human readable format. Other features of the system include:

● Power and network recovery automatic procedures
● FTP server to put the data on a central server
● Scheduled transfers

The system can be configured to provide logging for non-critical parameters including:

● System events
● Equipment failure
● Equipment performance and maintenance
● Energy usage

Alarms and Events Reporting
An important feature of the BMS/EMS system is its Alarms and Events functionality. All alarms and events are time stamped and logged for long term retention and validation to 21 CFR Part 11. Individual plant data can be configured to have one or a combination of the following alarms:

● Absolute alarms
● Deviation alarms
● Rate of Change alarms
● Delayed alarms
● Excursion alarms

The system can be configured to provide other alarms including;

● Sensor break
● Equipment failures
● Network failure
● Maintenance and calibration alarm

Alarms can be configured as critical, non-critical or as an Event. Critical alarms will require manual acknowledgement and non-critical will be auto-acknowledged. Alarm selection and setpoint settings are available to the users with the appropriate access level and critical alarms can be configured to require an Electronic Signature for changes. Alarm acknowledgement and all changes to alarm settings are automatically logged as required by 21 CFR part 11. All alarms and events are reported through local, central, and remote HMI panels. They are displayed in the Alarm Summary and Alarm History pages which provide a sort facility for the information. Alarms can be grouped by their criticality and function to ensure individual alarms can be quickly accessed.

Other features of the BMS/EMS alarm system include:

● Audible alarm notification
● Notification of alarm conditions to designated users on a designated telephone number
● Local printing of alarms and events

Easy to Use, Comprehensive Reporting
Review and Reporting

The BMS/EMS system provides a comprehensive review and reporting system. The system offers two methods for collecting data

● Local data collection – Data collected locally in a secure format and archived centrally in a filing system
● Central data collection – Data collected in a central historical SQL relational database

These methods may be combined and, in both cases, the system provides the facility to create reports for individual rooms. A number of standard report templates are provided along with the facility for users to create their own reports.

Information can be automatically transferred and accessed from standard Microsoft® Office packages.

● Realtime and historical trends
● Multiple data plots
● Search by batch or by room
● Batch trend analysis
● “Golden Batch” analysis
● Standard and custom SQL queries
● Direct insertion to Excel™, Word™
● Quick report generation with standard templates

Easy to Operate at every Level
Security Manager

Security Manager offers significant operation cost savings and ease of use by allowing maintenance of user accounts and passwords from one or multiple locations. If a user needs to change their password they can do so on a local instrument or PC and this will be automatically distributed across all systems to which they have access.

● A common security tool across multiple product ranges
● Change in one place, deploy to many
● Support for multiple security zones
● Built-in audit trail for 21 CFR Part 11 validation
● Automatic version control
● Support for electronic signatures

Maintenance and Calibration
Maintenance is an essential part of any BMS/EMS system. Maintenance information on various elements of the system (e.g. last calibration date, calibration due date, last maintenance date, maintenance due date) is shown on multiple displays throughout the system. The system can provide warnings if calibration/maintenance dates for
individual equipment are approaching and/or exceeded.

Access permission can be given to individual users to select maintenance modes for the following:

● Sensors
● Equipment (e.g. pumps, motors, valves)

Maintenance mode can also be selected for a given area e.g. a room or a zone of the plant. While in maintenance mode the individual equipment or area will be clearly identified on the display using colour and text. The system can be set to suppress alarms and stop logging parameters for associated equipment at this time.

Selection and the de-selection of the maintenance mode will be logged as an event in the audit trail.

Easy to use calibration tools are included in the system for use during maintenance mode. Selection and de-selection of the calibration mode is logged in the audit trail.

Total Lifecycle Support
Remote Alarm Notification

Nominated users can be quickly notified of alarm conditions via the telephone system.

The system offers:

■ Real-time alarm notification triggered from the plant system
■ Ensured the delivery of the messages
■ Easy to configure tools
■ Login facilities and security patterns
■ Redundancy options

Remote Monitoring
Remote users, including off-site, can access plant information via a secure web portal.

■ Remote real-time data visualisation
■ Multi language facilities
■ Support for multiple windows
■ Integrated information from diverse data sources

Services
Services need to be provided from the beginning of the project, though the project development and commissioning, and for the lifetime of the system.

Eurotherm offers a complete range of services such as:

● Expertise to assist with the User Requirement Specification
● Project, Application and Validation engineering
● Commissioning (e.g. calibration) and qualification engineering
● Training courses covering products, control theory, validation etc.
● Helpdesk and on call services
● Product services

Validation
BMS/EMS

A key requirement for BMS/EMS solutions is validation. Where environmental conditions (e.g. temperature, humidity, differential pressure, air flow, sterility, containment) have a direct impact on product purity, safety, quality or efficacy they need to be monitored against predetermined limits and logged. In this case the BMS/EMS system used for collecting and logging the data needs to be validated. According to ISPE guidelines, it is good practice to monitor the performance of equipment such as fans, coil and control components, but it is not a regulatory requirement.

Documentation
Validation documentation needs to be provided through the life cycle of the BMS/EMS system. Eurotherm can offer a range of documentation services following GAMP guidelines and in accordance with customer requirements:

■ User Requirement Specification
■ Functional Specification
■ Design Specification
■ Hardware Testing
■ Code Review
■ Factory Acceptance Test
■ Installation Qualification
■ Operational Qualification
■ Periodic review

Mean Kinetic Temperature (MKT)
Calculation

Measurement and recording of temperatures is vital to the storage of perishable goods, but there is more than one way to record an average. The ICH defines the mean kinetic temperature as being “A single derived temperature that, if maintained over a defined period of time, affords the same thermal challenge to a drug substance or drug product as would be experienced over a range of both higher and lower temperatures for an equivalent defined period”.

MKT expresses the cumulative thermal stress experienced by a product at varying temperatures during storage and distribution. It differs from other means (such as a simple numerical average or arithmetic mean) in that higher temperatures are given greater weight in computing the average, recognising the accelerated rate of thermal degradation of materials at higher temperatures.

Eurotherm minimizes the implementation and operation cost of providing MKT data by making all of the above methods as integral part of our solution with:

● A choice of stability testing period (hourly / daily /weekly)
● A choice of sampling frequency (from 1 minute to 1 hour)
● Option to remove individual probes from the calculation (e.g. during a calibration process)
● Corrective action in case stability is out of specification
● Secure and low cost custom reporting

The Fermentation Process
Fermentation is widely used within the Pharmaceutical and Food industries. It requires the cultivation in submerged culture of an identified micro-organism (mainly bacterial) as a monoculture under defined environmental conditions. The incubation regime imposed is designed to maximize the productivity of the organism of interest by providing optimal conditions for population growth (biomass). The product of interest might be a bioactive metabolite or recombinant protein.

During an incubation cycle a nutrient energy source (e.g. glucose) is added and the biomass and end product will increase as this is depleted.

Fermenter Design and Control
Incubation control necessitates the precise control of a number of parameters.

Of primary importance are:


Temperature, pH, DO2 or Redox, agitation, pressure, foam control, auxiliary feed or a combination of these controllers.

The control of these and any other parameters is most usually carried out in fermenter vessels specifically designed for the purpose and accommodating various working volumes depending on the yield and production requirements. Laboratory scale vessels could have a capacity of just 10 litres or less whereas production vessels may be as large as several thousand liters.

The smallest units may incorporate an electrical heater and feed stocks (e.g. Nutrient and pH control agents) may be fed from flasks via peristaltic pumps. Larger vessels have an integral jacket for controlling temperature via hot or cold water and allowing indirect sterilisation using injected steam. Where larger quantities of feed stock are required they may be held in separate pressurized tanks and fed via a ‘thrust pump’ arrangement of valves.

The actual fermentation process is known as the Incubation Phase and is just part of the batch cycle. A complete fermentation cycle can typically include the following steps (depending on vessel design):

● Empty (Blank) Sterilisation of vessel & pipework using direct Steam
● Injection
● Charging with base medium
● Indirect Sterilisation via Steam Injected into the vessel jacket
● Cooling & Jacket Drain
● Pre-Inoculation – Vessel environment under control
● Inoculation – Injection of a small sample of the monoculture
● Incubation – The Fermentation process itself
● Harvesting – Product removed ready for extraction processes

The R&D and Clinical Trials environments in which many small scale fermenters operate are such that it is not possible to predict the nature of any particular fermentation process either in terms of culture or incubation conditions. Production facilities must also cater for a variety of products each having precisely defined incubation profiles.

A control system must therefore provide flexibility in the way in which accurate and repeatable control of the fermentation environment is achieved and will include the following features:

● Precise loop control with Setpoint profile programming
● Recipe Management System for easy parameterization
● Sequential control for vessel sterilisation and more complex control strategies
● Secure collection of on-line data from the fermenter system for analysis and evidence
● Local operator display with clear graphics and controlled access to parameters

The EyconTM Visual Supervisor is an ideal solution for the fermentation process.

The Freeze Drying Process
Freeze drying is a slow batch process used in pharmaceutical & biochemical industries to extract dry product from an aqueous solution. The product is usually in phials placed on shelves in a vacuum chamber, which is first frozen and then evacuated. The shelves are then warmed up very slowly, boiling off the liquid, whilst the chamber is continuously evacuated through a cold condenser.

Once above zero degrees the chamber isolation valve is closed and a ‘Pressure Rise Test’ is performed to ensure the product is dry. Because of the high value of the product even automated freeze dryers go to wait states where the operator validates the readiness of the process to move on to the next stage.

Design & Control
There are many different arrangements for freeze dryers but the basics are outlined here.

Temperature can either be controlled electrically using heating mats on the shelves, or by circulating oil through pipes welded to the shelves in the chamber. The temperature of the chamber, shelves (and/or heating oil), plus condenser form part of the control and monitoring variables. The vacuum pressure is measured with a Pirani gauge. Control is achieved either by an analogue needle valve or coarse and fine admittance valves. A change over valve is used to switch the refrigeration plant from freezing the chamber to freezing the condenser. In the final drying stage, the condenser, by then full of ice, may be isolated. The freeze drying process is characterised by long stabilization periods, for example when the chamber is first frozen, to ensure all the product is completely frozen before the chamber evacuation starts. This is a typical situation where the operator may be required to visually check and confirm that the product and plant are ready for the evacuation to proceed.



The critical phase is the heating phase where the rate at which the water boils off must be slow enough not to damage the product. During this phase, the vacuum is held constant to give consistent conditions. The temperature ramp has to be held if the vacuum rises too much, indicating that the water is coming off too fast.

At the end of the Primary Drying heat ramp, a Pressure Rise Test (PRT) is performed. Here the chamber isolation valve is closed for a defined period - if the product is dry the vacuum is maintained, if the pressure rises more than a nominal amount the product is not completely dry. In this case, the isolation valve is then reopened for another period before a second test is performed. After the PRT, Secondary Drying takes place to ensure absolute dryness. The product is brought up to or just above ambient temperature.

The plant usually requires sterilization. This is achieved by an alternative strategy within the control system.

A control system must therefore provide excellent HMI and flexibility, in addition to accurate and reliable control of each freeze drying cycle. It will include the following features:

● Precise temperature control with ramping
● Sequential control of the temperature, vacuum and the refrigeration plant, both for freeze drying and sterilization
● Safety strategies to ensure product is not damaged as a result of plant failure
● Clear indications to the local operator of key process parameters and states
● Collection of data for analysis and evidence

The EyconTM Visual Supervisor is an ideal solution for this application.

Hydrogenator Design and Control
Hydrogenation is the chemical addition of hydrogen to a hydrocarbon in the presence of a catalyst, a severe form of hydrogen treating. Hydrogenation may be either destructive or non-destructive. In the former case, hydrocarbon chains are ruptured (cracked) and hydrogen is added where the breaks have occurred. In the latter, hydrogen is added to a molecule that is unsaturated with respect to hydrogen. In either case, the resulting molecules are highly stable.



Hydrogenator Design and Control
The use of hydrogen requires precautions against creating an explosive mix of hydrogen and air. Typically, a hydrogenation vessel undergoes a pressure test followed by several nitrogen purges before hydrogen is introduced. Similarly, at the end of the reaction process, the vessel is purged with nitrogen in order to leave it in a safe condition. Normally, a hardwired safety system confirms the pressure test and nitrogen purge phases before allowing the hydrogen line to be opened.



Hydrogenation requires high pressures to be maintained in the reaction vessel - giving problems over maintaining seals around agitators which in some cases require additional seal integrity checks or upgrades to incorporate magnetic coupling systems.

Hydrogenation also tends to be a highly exothermic reaction, resulting in demanding temperature control requirements.

The R&D and Clinical Trials environments in which many small scale hydrogenation vessels operate are such that facilities must cater for a variety of products each having precisely defined requirements both for the hydrogen addition itself and for the associated temperature profile.

A control system must therefore provide flexibility in the way in which accurate and repeatable control of the hydrogenation environment is achieved and will include the following features:

● Sequential control for vessel pressure testing, purging and hydrogen addition.
● Precise loop control for temperature and pressure (temperature setpoint profile programming is also available on the T800 if required).
● Secure collection of on-line data from the hydrogenation process for analysis and evidence.
● Local operator display with clear graphics and controlled access to parameters

The EyconTM Visual Supervisor is an ideal solution for this application.

The Tablet Coating Process
Many solid pharmaceutical dosage mediums are produced with coatings, either on the external surface of tablets, or on materials dispensed within gelatine capsules. Coating serves a number of purposes:

● Protects the tablet (or the capsule contents) from stomach acids
● Protects the stomach lining from aggressive drugs such as enteric coated aspirin
● Provides a delayed release of the medication
● Helps maintain the shape of the tablet

Ideally, the tablet should release the material gradually and the drug should be available for digestion beyond the stomach. The coating can be specially formulated to regulate how fast the tablet dissolves and where the active drugs are to be absorbed into the body after ingestion.

Many factors can affect the end-use properties of pharmaceutical tablets:

● Chemical composition
● Coating process
● Drying time
● Storage and environmental monitoring

Coating Process Design & Control
Tablet coating takes place in a controlled atmosphere inside a perforated rotating drum. Angled baffles fitted into the drum and air flow inside the drum provide means of mixing the tablet bed. As a result, the tablets are lifted and turned from the sides into the centre of the drum, exposing each tablet surface to an even amount of deposited/sprayed coating.



The liquid spray coating is then dried onto the tablets by heated air drawn through the tablet bed from an inlet fan. The air flow is regulated for temperature and volume to provide controlled drying and extracting rates, and at the same time, maintaining the drum pressure slightly negative relative to the room in order to provide a completely isolated process atmosphere for the operator.

Tablet coating equipment may include spray guns, coating pan, polishing pans, solution tanks, blenders and mixers, homogenizers, mills, peristaltic pumps, fans, steam jackets, exhaust and heating pipes, scales and filters. Tablet coating processes may include sugar coating (any mixtures of purified water, cellulose derivatives, polyvinyl, gums and sugar) or film coating (purified water, cellulose derivatives).

The coating process is usually a batch driven task consisting of the following phases:

● Batch identification and Recipe selection (film or sugar coating)
● Loading/Dispensing (accurate dosing of all required raw materials)
● Warming
● Spraying (application and rolling are carried out simultaneously)
● Drying
● Cooling
● Unloading

A control system must therefore provide flexibility in the way in which accurate and repeatable control of the coating environment is achieved and will include the following features:

● Precise loop control with setpoint profile programming
● Recipe Management System for easy parameterization
● Sequential control for complex control strategies
● Secure collection of on-line data from the coating system for analysis and evidence
● Local operator display with clear graphics and controlled access to parameters

The EyconTM Visual Supervisor is an ideal solution for the tablet coating process.

The Water Purification Process
Water purity is extremely important to pharmaceutical and biochemical industries. Suspended or dissolved particles, organic compounds, impurities and other contaminants prohibit the usage of tap water in laboratory applications and scientific research. Parameters such as resistivity, conductivity, size of particulate matter and concentration of microorganisms are used to categorize water quality and, therefore, specify intended uses for water. Some applications can tolerate the presence of specific impurities in the water, but others, such as High Performance Liquid Chromatography (HPLC) require removal of the majority of contaminants.



Contaminants
Water is an excellent solvent and can be sourced from almost anywhere on Earth. This property makes it prone to all kinds of contamination.

● Particulates: Silt and debris which can be removed by passing water through a 10 to 20 micron filter (or less if necessary).
● Microorganisms: Bacterial agents constitute a real challenge for water purification systems. Their growth rate, size and robustness require an efficient design (detection, removal from water inlet, inhibition of growth, etc.). Bacteria are measured in colony forming units per milliliter and can be killed with disinfectants. As a result, their secretions and cellular fragments must also be removed to avoid contamination.
● Endotoxins, pyrogens, DNA and RNA: Cellular fragments and bacterial by-products. Harmful to tissue cultures. Can be detected with a Limus Amoebocyte Lysate (LAL) test.
● Dissolved inorganic elements: Include phosphates, nitrates, calcium and magnesium, carbon dioxide, silicates, iron, chloride, fluoride, and any other natural or man-made chemicals resulting from exposure to the environment. Electrical conductivity (μSiemens/cm) is used to monitor high concentration of ions, while resistivity (MÙcm) is used to identify ions if present in small concentrations. These contaminants affect water hardness and alkalinity/acidity.
● Dissolved organic elements: Pesticides, plant and animal remains or fragments. Total Organic Carbon (TOC) analyzers are used to measure CO2 emitted by organics subjected to oxidization. Organic-free water is mainly used in applications where analysis of organic substances is carried out (e.g. HPLC, chromatography and mass spectrometry).

Scientific applications require elimination of certain types of contaminants. On the other hand, pharmaceutical productions require, in most cases, near-total removal of impurities (criteria dictated by specific standards or local/international regulatory bodies).


Purification Process
There are a number of methods commonly used to purify water. Their effectiveness is linked to the type of contaminant being treated and the type of application the water will be used for.

● Filtration: This process can take the form of any of the following:
     ● Coarse filtration: Also called particle filtration, it can utilize anything from a 1 mm sand filter, to a 1 micron cartridge filter.
     ● Micro filtration: Uses 1 to 0.1 micron devices to filter out bacteria. A typical implementation of this technique can be found in the brewing process.
     ● Ultra filtration: Removes pyrogens, endotoxins, DNA and RNA fragments.
     ● Reverse osmosis: Often referred to as RO, reverse osmosis is the most refined degree of liquid filtration. Instead of a filter, it uses a porous material acting as a unidirectional sieve that can separate molecular-sized particles.
● Distillation: Oldest method of purification. Inexpensive but cannot be used for an on-demand process. Water must be distilled and then stored for later use, making it again prone to contamination if not stored properly.
● Activated carbon adsorption: Operates like a magnet on chlorine and organic compounds.
● Ultraviolet radiation: At a certain wavelength, this might cause bacteria to be sterilized and other micro organics to be broken down.
● Deionization: Also known as ion exchange, it is used for producing purified water on-demand, by passing water through resin beds. Negatively charged (cationic) resin removes positive ions, while positively charged one (anionic) removes negative ions. Continuous monitoring and maintenance of the cartridges can produce the purest water.

Hot Water Sanitization
Sanitization of water purification equipment with hot water is achieved via an appropriate combination of exposure time and temperature. A primary use for this process is to deactivate viable microbes. It is worth mentioning that Endotoxin reduction is not achieved as a direct result of the hot water sanitization process.

Based on the feed water source, system operating conditions and the end-user's operating and maintenance procedures, traditional chemical cleaning processes may still be required.

Sanitization using hot water involves incorporating heat exchangers into the traditional clean in place (CIP) system to gradually heat and cool water circulating through the reverse osmosis membrane system. Membrane manufacturers commonly stipulate a controlled heating and cooling rate to protect against irreversible damage to the membrane and ensure the system's long-term performance.

A typical hot water sanitization sequence would consist of the following phases:

● Initialization (conditions checking)
● Heating
● Holding
● Cooling

A control system must therefore provide flexibility in the way in which accurate and repeatable control of the sterilization is achieved and will include the following features:

● Precise loop control with setpoint profile programming
● Sequential control for sanitation/sterilization
● Onscreen operator messaging
● Duty standby pump control
● Secure collection of on-line data from the purified water system for analysis and evidence
● Local operator display with clear graphics and controlled access to parameters

The EyconTM Visual Supervisor is an ideal solution for this application.

The Spray Drying Process
The spray drying process is older than might commonly be imagined. Earliest descriptions date from 1860 with the first patented design recorded in 1872. The basic idea of spray drying is the production of highly dispersed powders from a fluid feed by evaporating the solvent. This is achieved by mixing a heated gas with an atomized (sprayed) fluid of high surface-to-mass ratio droplets, ideally of equal size, within a vessel (drying chamber), causing the solvent to evaporate uniformly and quickly through direct contact.

Spray drying can be used in a wide range of applications where the production of a free-flowing powder is required. This method of dehydration has become the most successful one in the following areas:

● Pharmaceuticals
● Bone and tooth amalgams
● Beverages
● Flavours, colourings and plant extracts
● Milk and egg products
● Plastics, polymers and resins
● Soaps and detergents
● Textiles and many more

Almost all other methods of drying, including use of ovens, freeze dryers or rotary evaporators, produce a mass of material requiring further processing (e.g. grinding and filtering) therefore, producing particles of irregular size and shape. Spray drying on the other hand, offers a very flexible control over powder particle properties such as density, size, flow characteristics and moisture content.



Design and Control
The challenges facing both designers and users are to increase production, improve powder quality and reduce costs. This requires an understanding of the process and a robust control implementation.

Spray drying consists of the following phases:

● Feed preparation: This can be a homogenous, pumpable and free from impurities solution, suspension or paste.
● Atomization (transforming the feed into droplets): Most critical step in the process. The degree of atomization controls the drying rate and therefore the dryer size. The most commonly used atomization techniques are:

               1. Pressure nozzle atomization: Spray created by forcing the fluid through an orifice. This is an energy efficient method which also offers the narrowest particle size distribution.

               2. Two-fluid nozzle atomization: Spray created by mixing the feed with a compressed gas. Least energy efficient method. Useful for making extremely fine particles.

               3. Centrifugal atomization: Spray created by passing the feed through or across a rotating disk. Most resistant to wear and can generally be run for longer periods of time.

● Drying: A constant rate phase ensures moisture evaporates rapidly from the surface of the particle. This is followed by a falling rate period where the drying is controlled by diffusion of water to the surface of the particle.
● Separation of powder from moist gas: To be carried out in an economical (e.g. recycling the drying medium) and pollutant-free manner. Fine particles are generally removed with cyclones, bag filters, precipitators or scrubbers.
● Cooling and packaging.

A control system must therefore provide flexibility in the way in which accurate and repeatable control of the spray drying is achieved and will include the following features:

● Precise loop control with setpoint profile programming
● Recipe Management System for easy parameterisation
● Sequential control for complex control strategies
● Secure collection of on-line data from the system for analysis and evidence
● Local operator display with clear graphics and controlled access to parameters

The Sterilization Process (Autoclaves)
Through history, humans have used fire to purify items. Heat generated through application of high temperatures acts by disrupting membranes and denaturing proteins and nucleic acids. Burning, however, is a bit excessive for everyday usage.

Transmissible agents (such as spores, bacteria and viruses) can be eliminated through sterilization. This is different from disinfection, where only organisms that can cause disease are removed.

Some of the methods used to achieve sterilisation are:

● Autoclaves: Highly effective and inexpensive. Unsuitable for heat sensitive objects.
● Hot air ovens: Inefficient compared to autoclaves.
● Ethylene oxide: Suitable for heat sensitive items but leaves toxic residue on sterilized items.
● Low-temperature steam and formaldehyde: Effective for instruments with cavities or tubular openings.
● Sporicidal chemicals: Often used as disinfectants but can also sterilize instruments if used for prolonged periods.
● Irradiation: Gamma rays and accelerated electrons are excellent at sterilization.
● Gas plasma.

The preferred principle for sterilization is through heat, the autoclave being the most widely used method of achieving it.

In a dry air oven, it takes two hours at 160°C to kill spores of the bacterium Clostridium botulinium (associated with canned food). Using saturated steam, the same spores are killed in just five minutes at 121°C, proving that moist heat is more effective than dry heat.

Autoclave Design and Control

To be effective against spore forming bacteria and viruses, autoclaves need to:

● Have steam in direct contact with the material being sterilized (i.e. loading of items is very important).
● Create vacuum in order to displace all the air initially present in the autoclave and replacing it with steam.
● Implement a well designed control scheme for steam evacuation and cooling so that the load does not perish.

The efficiency of the sterilization process depends on two major factors. One of them is the thermal death time, i.e. the time microbes must be exposed to at a particular temperature before they are all dead. The second factor is the thermal death point or temperature at which all microbes in a sample are killed.

The steam and pressure ensure sufficient heat is transferred into the organism to kill them. A series of negative pressure pulses are used to vacuum all possible air pockets, while steam penetration is maximized by application of a succession of positive pulses.


Typical pressure cycles used in autoclaves are:

1)  Cycle for fabrics, assembled filter units and discard loads.

2)  Cycle for laboratory plastic and glassware.

3)  Cycle mainly used for discard loads.


Process performance can be confirmed by monitoring colour changes on indicator tape often taped onto packages or products to be autoclaved. Biological indicators such as the Attests can also be used. These contain Bacillus sterothermophilus spores, which are amongst the toughest organisms an autoclave will have to destroy. After a run in an autoclave, the internal glass in the Attest vial is shattered, allowing the spores into a differential liquid medium. If the autoclave has destroyed the spores, the medium remains a blue colour. Otherwise, the spores will metabolize, causing a yellow colour change after two days of incubation at 56°C.

A control system must therefore provide flexibility in the way in which accurate and repeatable control of the sterilization is achieved and will include the following features:

● Precise loop control with setpoint profile programming
● Recipe Management System for easy parameterization
● Sequential control for complex control strategies
● Secure collection of on-line data from the sterilization system for analysis and evidence
● Local operator display with clear graphics and controlled access to parameters

The EyconTM Visual Supervisor is an ideal solution for this application.

Ethylene Oxide (EtO) Sterilization Process
Ethylene Oxide (EtO) sterilization is mainly used to sterilize medical and pharmaceutical products that cannot support conventional high temperature steam sterilization - such as devices that incorporate electronic components, plastic packaging or plastic containers.

EtO gas infiltrates packages as well as products themselves to kill micro organisms that are left during production or packaging processes. This gas, mixed with air at a ratio of at least 3% EtO gas, forms an explosive mixture. Pure EtO gas boiling point is 10.73 ºC at atmospheric pressure. Most of the time, it is mixed with Nitrogen or CO2. This explosive condition requires Intrinsic Safe material (ATEX) zoning, for security of people as well as security of the process itself.

Safety of personnel is an important issue due to the harmful effect of EtO on humans. Polluted areas need to be alarmed using gas detectors set up at different locations to monitor any leak. Visual and audio alarm systems need to be provided. The system must inform any operator when a sterilization cell contains EtO.

When this toxic gas is removed from the room it needs to be treated using thermal burners, scrubbers or oxidation for environmental protection or be transported to an alternate facility for treatment.

EtO Sterilization process:

Most EtO sterilization lines involve three different stages. These can be separated into three different cells depending on the size or amount of devices to treat:

● PRE CONDITIONING
● STERILIZER
● DEGASSER




When cells are separated, automated loading/unloading systems are required. These save operator time as well as giving protection from exposure to a polluted environment, which could be detrimental to health.

PRE CONDITIONING STAGE

First, products need to go through a pre conditioning phase to make micro organisms grow. The batch load goes through a dwell time under a controlled environment of:

● Temperature
● Humidity




STERILIZER STAGE

Then the load goes through a long and complex sterilization cycle. Requirements of such a system are:

● Accurate temperature control.
● Availability of the control system.
● Accurate pressure and vacuum control.
● Easy displays of process phases
● Dedicated customer recipes.
● Auto batching release through tolerance tests.
● Reporting.
● Security interlocks between actuators.
● Alarming.
● Shut down strategies.
● Audit Trail facilities – Trending.
● 21CFR Part11




During this cycle, accurate temperature control is important and a heating jacket is used. As the overall duration of this cycle is around 60 hours, high availability of the system is vital and system redundancy is required. Doubling sensors, actuators and controllers as well as changeover facilities on these components, helps to ensure the product is sterilized even on hardware or software failure.

After the doors have been shut down and sealed correctly, the cycle can be started either manually or automatically. If any problem with door sealing is detected the cycle is interlocked and cannot start. Security interlocks are also used between air and EtO valves.

Once the cycle is started, easy to use displays are required to show:

● The actual phase of sterilization
● All the key set points and tolerances as loaded by the recipe
● All the key process values for the auto batch release facility


Control of vacuum and pressure is also required. Due to the toxic effect of EtO, water ring rotary pumps are used. The vacuum process needs to perform the emergency evacuation phase for a fast evacuation of gas.

The sterilization phases are:

● Cycle start delay to enable the system to start in stable conditions
● General cell temperature check
● Initial vacuum phase
● Leak rate test
● First flush
● Second flush
● DEC (Dynamic Environmental Conditioning)
● EtO gas injection
● Sterilization dwell time period under EtO
● Post dwell vacuum level
● First wash
● Second wash
● Final air admission
● Final chamber re-evacuation delay


During execution of these phases a batch report is generated. This report will include: tolerance checks, phase changes, alarms, events and critical process values. A key feature of the system is “auto batch” release. During the sterilization cycle if any abnormal condition occurs, the batch will be automatically stopped and condition(s) causing the stoppage will be identified. With this “auto batch” release facility operators do not have to wait until the end of the cycle and spend time going through the batch report to understand why it went wrong. With this feature, provided that batch is completed satisfactory it will be automatically forwarded to the degassing room without human check of tolerance, process values and alarms.

For each batch the operator selects appropriate product recipe. After recipe has been downloaded, the operator is given the opportunity to check if values are correct for this particular batch before starting the cycle.

When the batch is over an automatic print of the report can be performed. Batch logged files are also archived electronically for future review. Batch logged files could be searched by the following:

● Batch ID
● Customer name
● Recipe
● Product type
● Start and stop time

DEGASSER STAGE

Finally, products need to go through a degassing phase to remove any particle of EtO. The batch load goes over a dwell time under a temperature controlled environment


Pharmaceutical Environmental and Stability Chamber Monitoring
Monitoring of storage and production environments has become an important issue within the Pharmaceutical Industry. The FDA and other regulatory bodies require not only accurate measurement and storage of room parameters but if the storage medium is electronic then the methods used must comply with 21 CFR Part 11.

Stability Monitoring of medicinal products is an area also addressed by the ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) and the ICH final guidance (agreed Feb 2003), is now being adopted across Europe, Japan and the United States.

The FDA also states in its 21 CFR part 203 section that manufacturers, authorized distributors of drugs and their representatives shall store and handle all drug samples under conditions that will maintain their stability, integrity and effectiveness, and ensure that the drug samples are free of contamination, deterioration and adulteration.

With environmental chambers, temperature, humidity, particulate counts, differential pressure, lighting, gas levels and other environmental conditions can be controlled. This can be extended to equipment required to detect toxic gases and fume hood positions.

Regulatory bodies require that stability facilities have to meet the following criteria:

● Proper documentation, including SOPs and periodical reports
● Chambers and rooms have to be equipped with multiple sensors spread evenly throughout the controlled area
● Generous multilevel shelving providing orderly storage and proper exposure to the controlled environment
● Acceptable monitoring equipment (probes, recorders, etc.)
● Continuous recording of data and full traceability
● Corrective action taken when stability factors go outside the specifications

Alarms and Excursions

Detecting and announcing abnormal condition is a key requirement for the environmental monitoring systems.

Pharmaceutical companies have adopted various methods for capturing and announcing abnormal conditions. These include:

● Alarms if monitored values go outside a predefined value.
● Alarms on excursion conditions being breached (usually a set temperature or humidity for a particular time).
● Intelligent alarms (e.g. “alarm immediately if it is silent hours, after a period if it is during the day” or “delay the alarm if the room door is known to be open”).
● Alarms based on rolling yearly MKT.
● SMS or e-mail alerts triggered by alarms or events

Mean Kinetic Temperature (MKT)

Measurement and recording of temperatures is vital to the storage of perishable goods, but there is more than one way to record an average.

The ICH defines the mean kinetic temperature as being “a single derived temperature that, if maintained over a defined period of time, affords the same thermal challenge to a drug substance or drug product as would be experienced over a range of both higher and lower temperatures for an equivalent defined period”.

MKT expresses the cumulative thermal stress experienced by a product at varying temperatures, during storage and distribution. It differs from other means (such as a simple numerical average or arithmetic mean) in that higher temperatures are given greater weight in computing the average, thus, recognizing the accelerated rate of thermal degradation of materials at higher temperatures.

The mean kinetic temperature is calculated as being:



Tk being the mean kinetic temperature in Kelvin


ÄH is the heat activation in kJoule per mole


R is the universal gas constant in kJoule per mole per Kelvin


T1 and Tn are the temperature samples for periods 1 and n, respectively

n is the total number of periods in the calculation




There are a number of interpretations of how this calculation is achieved using real samples:

● All sample values fed into formula
● Maximum/minimum samples fed into formula separately (recommended by the FDA)
● Arithmetic mean of maximum and minimum fed into formula (recommended in the US Pharmacopeia and by the UK MCA)

Eurotherm offers all the above methods with:

● A choice of stability testing period (hourly / daily / weekly)
● A choice of sampling frequency (from 1 minute to 1 hour)
● Option to remove individual probes from calculation (e.g. during a calibration process)
● Corrective action in case stability is out of specification
● Secure and low cost custom reporting
● Significant reduction of the cost of ownership

What is 21 CFR Part 11?
Issued by the FDA (Food & Drug Administration) in 1997, the 21 CFR Part 11 final rule is intended to permit the widest possible use of electronic technology. This is divided into two main sections:

● Electronic Records
● Electronic Signatures

These are a natural extension to the traditional use of paper records. Paper records provide data security and can carry handwritten signatures to indicate that certain data is correct and log events, which took place. Attempted corruption of either the data or signatures is readily detectable.

In basic terms the requirement of Electronic Records is to provide secure data which can provide a high level of confidence as would be the case with paper records. Electronic signatures require that both operators and supervisors can electronically identify themselves in such a way as to be equivalent to handwritten signatures. The rule also permits the use of biometrics such as fingerprint or retinal scan devices.

The advance in electronic systems offers significant benefits for data retrieval and storage of data. The FDA developed the 21 CFR Part 11 rule to describe what they require to be comfortable that the electronic records and signatures are secure.

21 CFR Part 11 Made Easy!
From plant wide data access security management to single, secure recorders - let us help you choose a solution that is right for you.

Solutions designed for ease of validation
● Minimize validation time and testing by using standard, built-in features to meet the FDA's 21 CFR Part 11
● Data recording at every level, local and plant wide
● Never lose your data with cost-effective, multiple recording and secure back-up
● Centralised security system provides maintenance of user accounts and passwords from one or multiple locations
● Secure local data collection with automatic archiving across your network - truly designed to keep your data safe
● Remediation solutions for legacy systems - "Wrap & Comply"

Electronic Records
● Secure process values and audit trails (alarms, events, operator actions, log-in/log-out, operator notes, electronic signatures)
● Protection of data through binary, compressed and check-summed records
● Accurate time stamps are ensured using automatic Time Synchronization to a known clock source
● Provision for electronically copying data for archive
● Export facility providing viewing of secure records in human readable form

Electronic Signatures
● All user actions can be configured to require signing or require signing and authorization
● User specific access according to authority level
● Signature element controls unique user signature, password expiry, minimum password length, automatic log-off, automatic disabling and notification of failed login attempts
● Ensuring unique users by retiring and not deleting accounts

Central Security Manager with full audit trail
Security Manager offers significant operation cost savings and ease of use allowing maintenance of user accounts and passwords from one or multiple locations. If a user needs to change their password they can do so on a local instrument or PC and this will be automatically distributed across all systems to which they have access.

● A common security tool across multiple product ranges
● Change in one place, deploy to many
● Support for multiple security zones
● Built-in audit trail for 21 CFR Part 11 validation
● Automatic version control
● Support for electronic signatures

Additional Information
● The Pharmaceutical Project Life Cycle
● EurothermSuiteTM Operations Server/Viewer and 21 CFR Part 11
● Visual Supervisor and 21 CFR Part 11
● 6000 Series Recorders and 21 CFR Part 11
● FDA Guidance for Industry Part 11, Electronic Records; Electronic Signatures - Scope and Application
● Electronic Code of Federal Regulations (e-CFR): Title 21: Food and Drugs PART 11 - ELECTRONIC RECORDS; ELECTRONIC SIGNATURES
● www.fda.gov

Process Analytical Technology (PAT)
What is PAT?
PAT final Guidance was published September 2004. Its aim is to encourage the voluntary development and implementation of innovative pharmaceutical development, manufacturing, and quality assurance.

It represents the FDA's vision for future pharmaceutical product development and manufacture:

“A system for designing, analyzing, and controlling manufacturing through timely measurements (i.e. during processing) of critical quality and performance attributes of raw and in-process materials and processes, with the goal of ensuring final product quality.”

PAT is based on the principal that:
“quality cannot be tested into products; it should be built-in or should be by design.”
 
Conventional Manufacturing

● Generally inefficient with long cycle time, utilization <15%
● Scrap & rework 5-10%
● Lab testing on collected samples, generally a long waiting time
● Variable materials resulting in variable quality of product
● Generally low level of automation
● Perceived rigid regulatory requirement: Once validated try to avoid change
● Minimum innovation
● Generally "time defined" end point
PAT Based Manufacturing

● Reducing production cycle times by using on-, in-, and/or at-line measurements and controls
● Preventing rejects, scrap, and re-processing
● Continuous real time quality assurance, real-time release
● Increasing automation to improve operator safety and reduce human errors
● Improving energy and material use and increasing capacity
● Facilitating continuous processing to improve efficiency and manage variability
● Physical/Chemical/Biological attribute end point

What is involved in PAT based manufacturing?


● Understanding the process and all its critical sources of variability
● Timely measurement, i.e. during processing (on-, in-, or at-line)
● Control of critical quality and performance attributes including in-process materials (e.g. using process endpoints)
● Continuous improvement and knowledge management.
● Continuous validation (every lot is a validation lot) versus discrete 3-lot exercise.

EurothermSuite PAT Solution

EurothermSuite’s PAT solution is made up of the best-of-class “PAT tools”, designed to address the Life Science’s PAT requirement. It is a tightly integrated package which incorporates all the necessary tools for a PAT based manufacturing application.

EurothermSuite is by nature a modular DCS system which is ideal for the Life Science applications that often consists of a series of Unit Operations. These features allow the application of PAT to Unit Operations individually and therefore ensuring quality at every stage of the manufacturing process.

EurothermSuite’s PAT solution will help you to establish

● What are the effects of product components on quality?
● What sources of variability are critical?

It will enable you to manage the variability to ensure a predefined quality at the end of the manufacturing process; “quality is built into your product”. It includes the EurothermSuite Multivariate Package; Process Analyzers; Process control; and Continuous Improvement and Knowledge Management.

Process Control

EurothermSuite DCS solution has been widely used in the Life Science industry. With its high accurate analogue control it is ideal for monitoring and ensuring effective control of all critical attributes of the Process and ensuring operation in the desired state at every Unit Operation stage. It is ideal for providing advance control strategies including Feed Forward & Back, Predictors, Time Delays.

EurothermSuite DCS system is tightly integrated with the Multivariate package. Generally Process End Points are determined by the Multivariate package. At every stage of the process, once a Process End Point has been achieved, the EurothermSuite DCS system will take the necessary action to move to the next stage until the final Product has been accomplished.

Continuous Improvement & Knowledge Management

The use of Design of Experiments (DoE) to build a comprehensive model that captures the understanding of the process allows for many new opportunities. It becomes a simple procedure to scale up from a pilot production to full production. The model may also be used to determine other possible outcomes resulting from: variation in ingredients that could allow the use of lower cost materials, or alternative strategies in the control of the process e.g. fastest, lowest power consumption etc. A system validated by the FDA according to PAT principles may take account of future technological advances to improve efficiency and product quality without complete re-validation as there is a better understanding of the process and its variability is managed. As the principle of PAT is extended, so eventually the ultimate goal of real-time release may become a reality.

EurothermSuite Multivariate Package

EurothermSuite Multivariate Package provides for the (DoE) to build a better understanding of the process and thus determine the safe production window. DoE allows a model to be built that incorporates the relationship between the measured variable and the critical quality attributes of the process. Data acquisition of both multivariate and univariate data for electronic data records is built-in to enable compliance to 21CFR Part 11. The analysis and prediction engine uses the model from the DoE to predict the critical quality attributes of a process and to accurately determine Process Endpoints. With direct interfacing to the process control system it is able to effect control over the process in real-time to manage the inherent variability.

Process Analyzers

EurothermSuite’s Multivariate package supports a number of Process Analyzers (e.g. NIR, FIR, RAMAN, ACOUSTICS, etc) to measure biological, chemical and physical attributes of the process such as particle size, moisture content, homogeneity or concentration of active ingredient. One or more processor analyzer may incorporated in each process model.
 

LITERATURE
Life Sciences Catalogue  HA029301 Issue 2   (476 pages, 43M)